About: Treatment outcomes and prognostic factors of adult patients with non-malignancy associated secondary hemophagocytic lymphohistiocytosis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Treatment outcomes and prognostic factors of adult patients with non-malignancy associated secondary hemophagocytic lymphohistiocytosis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scholarly article by Jae-Ho Yoon et al published 13 September 2018 in Haematologica

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 2018 (uk) article scientifique publié en 2018 (fr) im September 2018 veröffentlichter wissenschaftlicher Artikel (de) scholarly article by Jae-Ho Yoon et al published 13 September 2018 in Haematologica (en)
publication date	wds:Q59352688-4A2E517F-6D5C-4E99-9EAA-3A9459FB15BD
publication date	2018-09-13 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q59352688-565DFB19-0E1C-4D4E-8784-0A1DF7D8D3E1
language of work or name	English
cites work	wds:Q59352688-048162EA-E451-4C1C-ADB6-F5759B59DE25 wds:Q59352688-06F5DFCE-D563-4C9D-BF78-C0CD52A5DAB7 wds:Q59352688-072B01E2-FEAC-4CF4-A68F-9746EB512B6F wds:Q59352688-09C00A46-58C2-4396-A0A2-63080C52CB22 wds:Q59352688-0ECF8D77-57FA-4928-9000-B1E73258DF66 wds:Q59352688-1718D659-E847-47AD-A199-68CC14E43B02 wds:Q59352688-198EE691-E588-4F12-BB02-AB937E7E0CC2 wds:Q59352688-1BA9021A-A89E-43DA-B21C-C4BBFBF22170 wds:Q59352688-1EC455A5-E308-41CD-9076-5523E09CD842 wds:Q59352688-48084E1F-FD52-4586-B679-D4835670DF6D wds:Q59352688-4C70D42F-C78A-4CC9-8BBC-87CC4C36C04E wds:Q59352688-5DA230E3-E017-4918-A440-5560E5B627C9 wds:Q59352688-5DF430E5-7532-47EC-9A3A-3BEAC1318E16 wds:Q59352688-6887F0A1-CADC-4741-A872-A90743E2C042 wds:Q59352688-7EA7FCF8-4A0D-4A28-9A1F-B578D05D2287 wds:Q59352688-7FDF0EA3-D7B9-4587-B7CA-7A5DA228874A wds:Q59352688-8AED4A08-2811-4A8F-AB1F-67206D0E53FF wds:Q59352688-8DDEE9AE-85A1-46B5-98AF-81393D7964F1 wds:Q59352688-996FB2AE-6E47-495D-B324-87D6E74CE288 wds:Q59352688-A5F265A1-F20D-46AA-BD7E-DD37C586B07D wds:Q59352688-B66DA199-8671-40ED-AB13-39B13D161E5E wds:Q59352688-B7DD982C-9CA0-44CA-B5C5-487F82D43182 wds:Q59352688-BE8AF49C-7230-4647-933C-4E9379B47023 wds:Q59352688-C1BDD7C6-FEF4-4B29-8CED-1BE1AE79BAB3 wds:Q59352688-C6537460-2E43-49F5-8145-6BEE4C332BA0 wds:Q59352688-CFFF1155-90EF-4FDB-A6D4-3D4C8AFD9138 wds:Q59352688-D1FEA5D0-8BDC-4B54-B08B-59D75648C2F3 wds:Q59352688-D265C807-9E44-40C4-88E1-888A940D27C8 wds:Q59352688-D53243BC-365D-4144-A2EE-D9BA3F6FD24C wds:Q59352688-D5F4F51D-1BB4-471D-9258-D43D66CC09B6 wds:Q59352688-D9E5BC94-7391-4F02-AB8A-67FB10036AAF wds:Q59352688-DD8E190F-DB5D-4F60-91E5-AC959FC8E503 wds:Q59352688-E13C481D-826D-463A-96B1-FB3B516CA7F1 wds:Q59352688-E3985749-354A-4057-B381-60D2B8C4B37D wds:Q59352688-EC883FE0-600B-465E-BC30-BF41331A517D wds:Q59352688-F5060461-42D7-4B66-B43C-9801AB59D51A wds:Q59352688-F539C91E-CA20-472C-9120-C7B5902F7C03 wds:Q59352688-F58610BB-6EC2-41FC-B69C-B32C47BBA99F wds:Q59352688-FD0AF4EB-CD81-475C-9ECA-710F3E80E1A9
cites work	Treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis (EBV-HLH); update 2010. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Hemophagocytic lymphohistiocytosis (HLH) and related disorders Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder. Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases. Familial and acquired hemophagocytic lymphohistiocytosis Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society Familial and acquired hemophagocytic lymphohistiocytosis How I treat hemophagocytic lymphohistiocytosis Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis Successful treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-94 protocol The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphohistiocytosis. A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases Multifactorial risk analysis of bone marrow histiocytic hyperplasia with hemophagocytosis in critically ill medical patients--a postmortem clinicopathologic analysis Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Alemtuzumab as a bridge to allogeneic SCT in atypical hemophagocytic lymphohistiocytosis Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan Treatment strategies for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH). Epstein-Barr virus-associated hemophagocytic syndrome: virological and immunopathological studies. Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients. Management of severe neutropenia with cyclosporin during initial treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab. Evaluation of NK cell function by flowcytometric measurement and impedance based assay using real-time cell electronic sensing system Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis Successful treatment of recurrent malignancy-associated hemophagocytic lymphohistiocytosis with a modified HLH-94 immunochemotherapy and allogeneic stem cell transplantation
author name string	wds:Q59352688-248CC085-DC13-48A7-AD24-EB5ECD941C96 wds:Q59352688-4068C98F-F446-4BF7-9452-31F754601F91 wds:Q59352688-4CC5DD02-1017-46B4-AFD6-B79C62DFA598 wds:Q59352688-59342ECD-A9DA-4402-B16E-9142A225920A wds:Q59352688-5A17B891-38B0-4336-AE31-C271FC82537E wds:Q59352688-5B74987A-3194-4E18-BAFC-E50A4B96D26B wds:Q59352688-6486854C-700F-4E2B-81FC-AD94AA304738 wds:Q59352688-65B6CA89-3204-4644-986A-6B926C825E34 wds:Q59352688-8C3DB46B-2228-46F3-AA34-529D5A55C977 wds:Q59352688-C4394CFD-D329-49EA-86F5-C7EE6066E198 wds:Q59352688-C78CE261-04CA-4342-A1DD-052B973D4055 wds:Q59352688-D08BA5BE-CF3D-4857-BB39-E384B01C040B

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software